SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

NAGELKERKE, Nico J.D. et al. Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ [online]. 2002, vol.80, n.2, pp. 89-96. ISSN 0042-9686.  http://dx.doi.org/10.1590/S0042-96862002000200003.

    1. EPI fact sheets by country — June 2000. Geneva: Joint United Nations Programme on HIV/AIDS; 2001. Available from: URL: http://www.unaids.org/ hivaidsinfo/statistics/june00/fact_sheets/index.html

    [ Links ]

    2. The HIV/AIDS pandemic — 1994 overview. Geneva: World Health Organization; 1994. Unpublished document WHO/GPA/TCO/SEF/94.4. Available from: URL: http://whqlibdoc.who.int/hq/1994/WHO_GPA_ TCO_SEF_94.4.pdf

    [ Links ]

    3. AIDS epidemic update. Geneva: Joint United Nations Programme on HIV/AIDS; 1998.

    [ Links ]

    4. National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India; 2001. Available from: URL: http://naco.nic.in

    [ Links ]

    5. Best practice digest — documents. Geneva: Joint United Nations Programme on HIV/AIDS; 2001. Available from: URL: http://www.unaids.org/bestpractice/digest/table.html#sex

    [ Links ]

    6. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-6.

    [ Links ]

    7. Grosskurth H, Gray R, Hayes R, Mabey D, Wawer M. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 2000;355:1981-7.

    [ Links ]

    8. Grosskurth H. From Mwanza and Rakai to Beijing and Moscow? STD control and HIV prevention. Sexually Transmitted Infections 1999;75:83-5.

    [ Links ]

    9. Gibb DM, Tess BH. Interventions to reduce mother-to-child transmission of HIV infection: new developments and current controversies. AIDS 1999; 13(Suppl A):S93-102.

    [ Links ]

    10. Mofenson LM, McIntyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet 2000;355:2237-44.

    [ Links ]

    11. Dabis F, Newell ML, Fransen L, Saba J, Lepage P, Leroy V, et al. Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIV. Health Policy and Planning 2000;15:34-42.

    [ Links ]

    12. Garnett GP, Anderson RM. Antiviral therapy and the transmission dynamics of HIV-1. Journal of Antimicrobial Chemotherapy 1996;37:135-50.

    [ Links ]

    13. Aggarwal OP, Sharma AK, Indrayan A. HIV/AIDS research in India. New Delhi: National AIDS Control Organisation; 1997.

    [ Links ]

    14. MacDonald DS. Notes on the socio-economic and cultural factors influencing the transmission of HIV in Botswana. Social Science and Medicine 1996; 42:1325-33.

    [ Links ]

    15. Jochelson K, Mothibeli M, Leger JP. Human immunodeficiency virus and migrant labor in South Africa. International Journal of Health Services 1991;21(1):157-73.

    [ Links ]

    16. Rodrigues JJ, Mehendale SM, Shepherd ME, Divekar AD, Gangakhedkar RR, Quinn TC, et al. Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India. British Medical Journal 1995; 311:283-6.

    [ Links ]

    17. Pais P. HIV and India: looking into the abyss. Tropical Medicine and International Health 1996;1(3):295-304.

    [ Links ]

    18. Gangakhedkar RR, Bentley ME, Divekar AD, Gadkari D, Mehendale SM, Shepherd ME, et al. Spread of HIV infection in married monogamous women in India. JAMA 1997;278:2090-2.

    [ Links ]

    19. Carael M, Cleland J, Adeokun L. Overview and selected findings of sexual behaviour surveys. AIDS 1991;5(Suppl 1):S65-74.

    [ Links ]

    20. Carael M, Cleland J, Deheneffe JC, Ferry B, Ingham R. Sexual behaviour in developing countries: implications for HIV control. AIDS 1995;9(10):1171-5.

    [ Links ]

    21. Carael M, Van de Perre PH, Lepage PH, Allen S, Nsengumuremyi F, Van Goethem C, et al. Human immunodeficiency virus transmission among heterosexual couples in Central Africa. AIDS 1988;2(3):201-5.

    [ Links ]

    22. Wilson D, Chiroro P, Lavelle S, Mutero C. Sex worker, client sex behaviour and condom use in Harare, Zimbabwe. AIDS Care 1989;1(3):269-80.

    [ Links ]

    23. Pickering H, Okongo M, Nnalusiba B, Bwanika K, Whitworth J. Sexual networks in Uganda: casual and commercial sex in a trading town. AIDS Care 1997; 9(2):199-207.

    [ Links ]

    24. Pickering H, Okongo M, Bwanika K, Nnalusiba B, Whitworth J. Sexual behaviour in a fishing community on Lake Victoria, Uganda. Health Transition Review 1997;7(1):13-20.

    [ Links ]

    25. Lagarde E, Auvert B, Carael M, Laourou M, Ferry B, Akam E, et al. Concurrent sexual partnerships and HIV prevalence in five urban communities of sub- Saharan Africa. AIDS 2001;15(7):877-84.

    [ Links ]

    26. Nagelkerke NJD, Jha P, de Vlas SJ, Korenromp EL, Moses S, Blanchard JF, et al. Modelling the HIV/AIDS epidemic in India and Botswana: the effects of interventions. Internet communication, 23 November 2001. Available from: URL: http://www.cmhealth.org/docs/wg5_paper4.pdf

    [ Links ]

    27. Confronting AIDS. Public priorities in a global epidemic. Washington (DC): World Bank; 1997.

    [ Links ]

    28. Hethcote HW, Yorke JA. Gonorrhea transmission dynamics and control. Berlin: Springer; 1984. Springer Lecture Notes in Biomathematics 56.

    [ Links ]

    29. Jha P, Nagelkerke NJD, Ngugi EN, Prasada Rao JVR, Willbond B, Moses S, et al. Reducing HIV transmission in developing countries. Science 2001;292:224-5.

    [ Links ]

    30. Moses S, Plummer FA, Ngugi EN, Nagelkerke NJ, Anzala AO, Ndinya-Achola JO. Controlling HIV in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group. AIDS 1991;5:407-11.

    [ Links ]

    31. Jana S, Bandyopadhyay N, Mukherjee S, Dutta N, Basu I, Saha A. STD/HIV Intervention with sex workers in West Bengal, India. AIDS 1998; 12(Suppl B):S101-8.

    [ Links ]

    32. Bhave G, Lindan CP, Hudes ES, Desai S, Wagle U, Tripathi SP, et al. Impact of an intervention on HIV, sexually transmitted diseases, and condom use among CSW in Bombay, India. AIDS 1995;9(Suppl 1):S21-30.

    [ Links ]

    33. Jana S, Singh S. Beyond medical model of STD intervention — lessons from Sonagachi. Indian Journal of Public Health 1995;39(3):125-31.

    [ Links ]

    34. Koremromp EL, DeVlas SJ, Nagelkerke NJD, Habbema JDF. Estimating the magnitude of STD cofactor effects on HIV transmission — how well can it be done? Sexually Transmitted Diseases 2001;28(11):613-21.

    [ Links ]

    35. Matthys F, Boelaert M. Preventing HIV-1: lessons from Mwanza and Rakai. Lancet 1999;353:1523-4.

    [ Links ]

    36. Kvale G. Preventing HIV-1: lessons from Mwanza and Rakai. Lancet 1999; 353:1522-3.

    [ Links ]

    37. Nicoll A, Johnson AM, Adler MW, Laga M. Preventing HIV-1: lessons from Mwanza and Rakai. Lancet 1999;353:1522.

    [ Links ]

    38. Hitchcock P, Fransen L. Preventing HIV infection: lessons from Mwanza and Rakai. Lancet 1999;353:513-5.

    [ Links ]

    39. Koremromp EL, Van Vliet C, Grosskurth H, Gavyole A, Van der Ploeg CP, Fransen L, et al. Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS 2000;14:573-93.

    [ Links ]

    40. Gray RH, Wawer MJ, Sewankambo NK, Serwadda D, Li C, Moulton LH, et al. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team. AIDS 1999;13:2113-23.

    [ Links ]

    41. Hudson CP. Community-based trials of sexually transmitted disease treatment: repercussions for epidemiology and disease prevention. Bulletin of the World Health Organization 2001;79:48-60.

    [ Links ]

    42. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.

    [ Links ]

    43. Nduati R. Breastfeeding and HIV-1 infection. A review of current literature. Advances in Experimental Medicine and Biology 2000;478:201-10.

    [ Links ]

    44. Nagi BS. Child survival and safe motherhood: experiences from India. New Delhi: Vedams Books; 2000.

    [ Links ]

    45. Rogers PA, Sinka KJ, Molesworth AM, Evans BG, Allardice GM. Survival after diagnosis of AIDS among adults resident in the United Kingdom in the era of multiple therapies. Communicable Disease and Public Health 2000;3:188-94.

    [ Links ]

    46. Wong T, Chiasson MA, Reggy A, Simonds RJ, Heffess J, Loo V. Antiretroviral therapy and declining AIDS mortality in New York City. Journal of Urban Health 2000;77:492-500.

    [ Links ]

    47. Telenti A, Paolo Rizzardi G. Limits to potent antiretroviral therapy. Review of Medical Virology 2000;10:385-93.

    [ Links ]

    48. Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 2000;14:117-21.

    [ Links ]

    49. Van der Straten, Gomez CA, Saul J, Quan J, Padian N. Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS 2000;14:F47-54.

    [ Links ]

    50. Centers for Disease Control. Increases in unsafe sex and rectal gonorrhea among men who have sex with men — San Francisco, California, 1994–1997. Morbidity and Mortality Weekly Report 1999;48:45-8.

    [ Links ]

    51. Moses S, Bailey RC, Ronald AR. Male circumcision: assessment of health benefits and risks. Sexually Transmitted Infections 1998;74:368-73.

    [ Links ]

    52. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine 2000;342:921-9.

    [ Links ]

    53. Moses S, Nagelkerke NJ, Blanchard J. Analysis of the scientific literature on male circumcision and risk for HIV infection. International Journal of STD and AIDS 1999;10:626-8.

    [ Links ]

    54. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1992.

    [ Links ]

    55. Shiboski SC, Padian NS. Epidemiologic evidence for time variation in HIV infectiousness. Journal of the Acquired Immune Deficiency Syndrome and Human Retrovirology 1998;19:527-35.

    [ Links ]

    56. Farmer P, Leandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001;358(9279):404-9.

    [ Links ]

    57. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001;358(9279):410-4.

    [ Links ]

    58. Anderson RM. The pandemic of antibiotic resistance. Nature Medicine 1999;5:147-9.

    [ Links ]

    59. Kochi A, Vareldzis B, Styblo K. Multidrug-resistant tuberculosis and its control. Research on Microbiology 1993;144:104-10.

    [ Links ]

    60. Ferguson NM, Garnett GP. More realistic models of sexually transmitted disease transmission dynamics: sexual partnership networks, pair models, and moment closure. Sexually Transmitted Diseases 2000;27:600-9.

    [ Links ]

    61. Van Vliet C, Meester EI, Korenromp EL, Singer B, Bakker R, Habbema JD. Focusing strategies of condom use against HIV in different behavioural settings: an evaluation based on a simulation model. Bulletin of the World Health Organization 2001;79(5):442-54.

    [ Links ]

    62. Van de Ploeg CPB, Van Vliet C, DeVlas SJ, Ndinya-Achola JO, Fransen L, VanOortmarssen GJ, et al. STDSIM: A microsimulation model for decision support in STD control. Interfaces 1998;28:84-100.

    [ Links ]

    63. Garnett GP, Bartley LM, Cameron DW, Anderson RM. Both a 'magic bullet' and good aim are required to link public health interests and health care needs in HIV infection. Nature Medicine 2000;6:261-2.

    [ Links ]

    64. Blower SM, Gershengorn HB, Grant RM. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000;287:650-4.

    [ Links ]

    65. De Ronde A, van Dooren M, van Der Hoek L, Bouwhuis D, de Rooij E, van Gemen B, et al. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. Journal of Virology 2001;75:595-602.

    [ Links ]

    66. Brenner B, Wainberg MA, Salomon H, Rouleau D, Dascal A, Spira B, et al. Resistance to antiretroviral drugs in patients with primary HIV-1 infection. International Journal of Antimicrobial Agents 2000;16:429-34.

    [ Links ]

    67. Hanna GJ, D'Aquila RT. Antiretroviral drug resistance in HIV-1. Current Infectious Disease Reports 1999;1:289-97.

    [ Links ]

    68. Weinstock H, Respess R, Heneine W, Petropoulos CJ, Hellmann NS, Luo CC, et al. Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998. Journal of Infectious Diseases 2000;182:330-3.

    [ Links ]

    69. Wenger SA, Brodine SK, Mascola JR, Tasker SA, Shaffer RA, Starkey MJ, et al. Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naive HIV-1 infected US military personnel. AIDS 2000;14:1009-15.

    [ Links ]

    70. Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK, et al. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Annals of Internal Medicine 1999;131:502-6.

    [ Links ]

    71. Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, et al. Reduced antiretroviral drug susceptibility among patients with primary HIV infection. JAMA 1999;282:1142-9.

    [ Links ]

    72. Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, et al. HIV-1 drug resistance in newly infected individuals. JAMA 1999;282:1135-41.

    [ Links ]

    73. Yerley S, Kaiser L, Race E, Bru JP, Clavel F, Perrin L. Transmission of antiretroviral- drug-resistant HIV-1 variants. Lancet 1999;354:729-33.

    [ Links ]

    74. Brenner BG, Wainberg MA. The role of antiretrovirals and drug resistance in vertical transmission of HIV-1 infection. Annals of the New York Academy of Sciences 2000;918:9-15.

    [ Links ]

    75. Stover J, Way P. Projecting the impact of AIDS on mortality. AIDS 1998; 12(Suppl 1):S29-39.

    [ Links ]

    76. Stover J. Influence of mathematical modeling of HIV and AIDS on policies and programs in the developing world. Sexually Transmitted Diseases 2000; 27:572-8.

    [ Links ]

    77. Cleghorn FR, Jack N, Murphy JR, Edwards J, Mahabir B, Paul R, et al. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population. American Journal of Epidemiology 1998;147:834-9.

    [ Links ]

    78. Brookmeyer R, Mehendale SM, Pelz RK, Shepherd ME, Quinn T, Rodrigues JJ, et al. Estimating the rate of occurrence of new HIV infections using serial prevalence surveys: the epidemic in India. AIDS 1996;10:924-5.

    [ Links ]